Correction to: Cell Death and Disease https://doi.org/10.1038/s41419-019-1696-9, published online 12 June 2019
The original version of this article contained an error in Figure 5E. The representative image of transmission electron microscope (EM) analysis for FGF1ΔHBS treatment group was accidentally assigned to the Control group when the authors prepared this figure in PowerPoint (bottom line of Figure 5E). The relevant results previously reported as statistically significant remain to be unchanged. The authors note that this mistake doesn’t affect the conclusion in this study. The correct image is given below.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Wang, D., Jin, M., Zhao, X. et al. Correction: FGF1ΔHBS ameliorates chronic kidney disease via PI3K/AKT mediated suppression of oxidative stress and inflammation. Cell Death Dis 14, 277 (2023). https://doi.org/10.1038/s41419-023-05808-x
Published:
Version of record:
DOI: https://doi.org/10.1038/s41419-023-05808-x
